78 related articles for article (PubMed ID: 1485594)
1. Expression of the epidermal growth factor receptor in squamous carcinoma cell lines of the larynx and hypopharynx.
Bujía J; Wustrow TP
Allergol Immunopathol (Madr); 1992; 20(4):152-6. PubMed ID: 1485594
[TBL] [Abstract][Full Text] [Related]
2. Heterologous epidermal growth factor receptor (EGF-R) expression in larynx cancer cell lines: evidence for the existence of structurally modified receptors.
Bujía J; Wustrow TP
Acta Otolaryngol; 1993 Nov; 113(6):789-92. PubMed ID: 8291440
[TBL] [Abstract][Full Text] [Related]
3. Variations of EGF-R surface expression in squamous cell carcinomas of the head and neck region.
Mandic R; Eikelkamp N; Peldszus R; Sadowski M; Sesterhenn AM; Dünne AA; Werner JA
Anticancer Res; 2001; 21(5):3413-8. PubMed ID: 11848502
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
Somers KD; Cartwright SL; Schechter GL
Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294
[TBL] [Abstract][Full Text] [Related]
5. Activation of the autocrine transforming growth factor alpha pathway in human squamous carcinoma cells.
Reiss M; Stash EB; Vellucci VF; Zhou ZL
Cancer Res; 1991 Dec; 51(23 Pt 1):6254-62. PubMed ID: 1933886
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
[TBL] [Abstract][Full Text] [Related]
7. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Bárdos H; Juhász A; Répássy G; Adány R
Thromb Haemost; 1998 Nov; 80(5):767-72. PubMed ID: 9843169
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
9. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
10. Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.
Merlino GT; Xu YH; Richert N; Clark AJ; Ishii S; Banks-Schlegel S; Pastan I
J Clin Invest; 1985 Mar; 75(3):1077-9. PubMed ID: 2984254
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
12. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B.
Carey TE; Van Dyke DL; Worsham MJ; Bradford CR; Babu VR; Schwartz DR; Hsu S; Baker SR
Cancer Res; 1989 Nov; 49(21):6098-107. PubMed ID: 2790823
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activity of monoclonal antibody CIBCNSH3 generated to the human EGF receptor.
Udayachander M; Dean CJ; Meenakshi AN; Sivakumar N; Babu PB; Sivakumar J
Hum Antibodies; 1997; 8(2):60-4. PubMed ID: 9289389
[TBL] [Abstract][Full Text] [Related]
15. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
[TBL] [Abstract][Full Text] [Related]
16. Ligand activation of overexpressed epidermal growth factor receptor results in colony dissociation and disturbed E-cadherin function in HSC-1 human cutaneous squamous carcinoma cells.
Fujii K; Furukawa F; Matsuyoshi N
Exp Cell Res; 1996 Feb; 223(1):50-62. PubMed ID: 8635495
[TBL] [Abstract][Full Text] [Related]
17. Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.
Modjtahedi H; Eccles S; Sandle J; Box G; Titley J; Dean C
Cancer Res; 1994 Apr; 54(7):1695-701. PubMed ID: 8137284
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells.
Budillon A; Tagliaferri P; Caraglia M; Torrisi MR; Normanno N; Iacobelli S; Palmieri G; Stoppelli MP; Frati L; Bianco AR
Cancer Res; 1991 Feb; 51(4):1294-9. PubMed ID: 1997168
[TBL] [Abstract][Full Text] [Related]
19. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
Hoffmann T; Hafner D; Ballo H; Haas I; Bier H
Anticancer Res; 1997; 17(6D):4419-25. PubMed ID: 9494544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
